ClinicalTrials.Veeva

Menu

The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma (pCND)

A

Assiut University

Status

Unknown

Conditions

Papillary Thyroid Cancer

Treatments

Procedure: central neck dissection

Study type

Observational

Funder types

Other

Identifiers

NCT04076514
Ahmed1712

Details and patient eligibility

About

The benefits of prophylactic central neck dissection (pCND) remain controversial in clinically node-negative (cN0) papillary thyroid carcinoma (PTC). This study main goal is to investigate benefits of prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma.

Full description

Papillary thyroid carcinoma (PTC) is the most common type of differentiated thyroid carcinoma. Recurrence rate is still high. The standard management is total thyroidectomy. regional lymph node metastasis is noted in recurrent cases. Some studies stated benefits of central neck dissection in orevention of recurrence and others said there is no benefits. so prophylactic central neck dissection (pCND) remain controversial in clinically node-negative (cN0) papillary thyroid carcinoma (PTC).

Enrollment

20 estimated patients

Sex

All

Ages

16+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients with papillary thyroid cancer with clinically node negative.

Exclusion criteria

  • patients with clinical evidence of nodal metastases.
  • patients with a previous history of thyroidectomy.
  • patients with mixed-type papillary thyroid cancer.

Trial design

20 participants in 1 patient group

patients with node negative papillary thyroid carcinoma
Treatment:
Procedure: central neck dissection

Trial contacts and locations

1

Loading...

Central trial contact

ahmed kamel ali

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems